JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by AKESTER, J. M.
Right arrow Articles by BRODY, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by AKESTER, J. M.
Right arrow Articles by BRODY, M. J.
Journal of Pharmacology And Experimental Therapeutics, Vol. 170, Issue 2, 287-293, 1969
Copyright © 1969 by American Society for Pharmacology and Experimental Therapeutics


MECHANISM OF VASCULAR RESISTANCE CHANGES PRODUCED IN SKIN AND MUSCLE BY HALOTHANE

JOHN M. AKESTER 1 and MICHAEL J. BRODY 1

1 Department of Pharmacology, College of Medicine, University of Iowa, Iowa City, Iowa

The vasoconstrictor action of halothane in skeletal muscle was shown previously to be mediated indirectly by liberation of vasopressin. In the present experiments it was demonstrated that during halothane (1%) inhalation vascular resistance in skin is decreased at the time when muscle vascular resistance increases. An attempt was made to determine why halothane administration fails to increase vascular resistance in skin vessels, which are presumably exposed to the same concentration of vasopressin. Responses to norepinephrine, angiotensin, vasopressin and sympathetic nerve stimulation were measured in isolated and separately perfused skin and muscle vessels. Halothane administration produced a parallel reduction in respouses of skin and muscle vessels to norepinephrine, angiotensin and sympathetic nerve stimulation. However, the response to vasopressin in skin was depressed significantly more than in muscle. It was concluded that halothane administration produces a general depression of vasoconstrictor responses but specifically depresses the response to vasopressin in skin, thus preventing an increase in skin vascular resistance.

Submitted on January 13, 1969
Accepted on September 1, 1969







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1969 by the American Society for Pharmacology and Experimental Therapeutics.